A so-so CHF trial result would be terribly disappointing. And I agree the SP would get smashed.
But with the FDA decision hot on its heels and almost certainly good news (and in turn a profitable company).
I will be ready to take advantage of the last dirt cheap SP.
Long term it will still be a good buy.
Maybe just not to the statospheric levels we are hoping for. Or at least not so quickly.
But don't forget. 800 patents 69 patent families ...and counting.
CHF is important. But it won't make or break the company imo.
MSB Trading - 2020, page-266
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.070(6.45%) |
Mkt cap ! $1.318B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $20.88M | 17.94M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 59978 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 34019 | 3 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.070 ( 5.63 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 3733217 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| MSB (ASX) Chart |